FDA Approved: XYWAV — Original Application (Jazz Pharmaceuticals, Inc.)

View source ↗

Summary

FDA approved XYWAV, a lower-sodium oxybate formulation, under an original application by Jazz Pharmaceuticals for the treatment of narcolepsy (with or without c…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Narcolepsy

Drugs mentioned

• XYWAV (CALCIUM, MAGNESIUM, POTASSIUM, AND SODIUM OXYBATES)

Snippet

ORIG AP for XYWAV (CALCIUM, MAGNESIUM, POTASSIUM, AND SODIUM OXYBATES)